Please help prevent the Novobiotronics Research Laboratory from closing forever!

For the past 16 years, we have dedicated ourselves to researching the frequencies needed to slow and destroy cancer, but this vital research will end forever without your help today.

Our Novobiotronics laboratory was the ONLY lab in the world doing the very specific and detailed work on finding the most effective frequencies (broadcast by a plasma antenna) to lay the groundwork needed for a nontoxic, noninvasive, painless and inexpensive future cancer treatment.

We have lost the upstate New York laboratory space that was donated to us from 2011 through 2022, but we are not giving up! With your support, we will keep this vital research moving forward!

Novobiotronics is moving its research laboratory to Florida but we can’t do it without your help!

Since the end of 2022, we have been busy preparing the way to continue our research in the state of Florida. We have already successfully overcome numerous bureaucratic hurdles and spent considerable time working with area specialists to help estimate the cost of re-establishing our research lab in Florida. We were able to bring our most important and vital portable electronic equipment from the NY lab and it is now in temporary storage in Florida, awaiting the necessary construction work and large equipment needed to establish the Florida Novobiotronics Research Laboratory.

We are ready to continue this vital research work, but without your help, it may end forever.

Please donate and share this fundraising link with friends, family and colleagues. Let’s all join together for a better future cancer treatment that is nontoxic, noninvasive, painless and inexpensive!

Anthony Holland President Novobiotronics Inc.

More information about Novobiotronics Inc.: Novobiotronics Inc. is a nonprofit 501©(3) educational and scientific company actively engaged in research on the effects of frequency-specific oscillating pulsed electric fields (OPEF) (broadcast by a plasma tube antenna) on human cancer cells and pathogenic bacteria. We are working to lay the foundation for a future cancer treatment that is nontoxic, noninvasive, painless and inexpensive.